130 related articles for article (PubMed ID: 7513545)
21. Chronic myelocytic leukemia--Part I: History, clinical presentation, and molecular biology.
Randolph TR
Clin Lab Sci; 2005; 18(1):38-48. PubMed ID: 15747785
[TBL] [Abstract][Full Text] [Related]
22. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
[No Abstract] [Full Text] [Related]
23. B-lymphoid/myeloid stem cell origin in Ph-positive acute leukemia with myeloid markers.
Akashi K; Taniguchi S; Nagafuji K; Harada M; Shibuya T; Hayashi S; Gondo H; Niho Y
Leuk Res; 1993 Jul; 17(7):549-55. PubMed ID: 8326735
[TBL] [Abstract][Full Text] [Related]
24. Molecular insights into the Philadelphia translocation.
Heisterkamp N; Groffen J
Hematol Pathol; 1991; 5(1):1-10. PubMed ID: 2050600
[TBL] [Abstract][Full Text] [Related]
25. DNA sequence analysis of the major breakpoint cluster region of the BCR gene rearranged in Philadelphia-positive human leukemias.
Sowerby SJ; Kennedy MA; Fitzgerald PH; Morris CM
Oncogene; 1993 Jun; 8(6):1679-83. PubMed ID: 8502487
[TBL] [Abstract][Full Text] [Related]
26. Study of the BCR/ABL rearrangement in patients with two Philadelphia chromosomes.
González FA; Villegas A; Asenjo S; Alvarez A; Ferro MT; Resino M
Cancer Genet Cytogenet; 1993 Oct; 70(2):153-4. PubMed ID: 8242601
[No Abstract] [Full Text] [Related]
27. The involvement of Bcr in leukemias with the Philadelphia chromosome.
Arlinghaus RB
Crit Rev Oncog; 1998; 9(1):1-18. PubMed ID: 9754444
[TBL] [Abstract][Full Text] [Related]
28. No evidence for genomic imprinting of the human BCR gene.
Fioretos T; Heisterkamp N; Groffen J
Blood; 1994 Jun; 83(12):3441-4. PubMed ID: 8204871
[TBL] [Abstract][Full Text] [Related]
29. The function of BCR/ABL and related proto-oncogenes.
Gotoh A; Broxmeyer HE
Curr Opin Hematol; 1997 Jan; 4(1):3-11. PubMed ID: 9050373
[TBL] [Abstract][Full Text] [Related]
30. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
31. Aberrant methylation of the major breakpoint cluster region in chronic myeloid leukemia.
Litz CE; Vos JA; Copenhaver CM
Blood; 1996 Sep; 88(6):2241-9. PubMed ID: 8822945
[TBL] [Abstract][Full Text] [Related]
32. P210 BCR-ABL is complexed to P160 BCR and ph-P53 proteins in K562 cells.
Campbell ML; Li W; Arlinghaus RB
Oncogene; 1990 May; 5(5):773-6. PubMed ID: 2140598
[TBL] [Abstract][Full Text] [Related]
33. The BCR gene recombines preferentially with Alu elements in complex BCR-ABL translocations of chronic myeloid leukaemia.
Jeffs AR; Benjes SM; Smith TL; Sowerby SJ; Morris CM
Hum Mol Genet; 1998 May; 7(5):767-76. PubMed ID: 9536079
[TBL] [Abstract][Full Text] [Related]
34. A new chromosomal breakpoint in Ph positive, bcr negative chronic myelogenous leukemia. Report of a case.
Negrini M; Tallarico A; Pazzi I; Castagnoli A; Cuneo A; Castoldi GL
Cancer Genet Cytogenet; 1992 Jul; 61(1):11-3. PubMed ID: 1353407
[TBL] [Abstract][Full Text] [Related]
35. Molecular characterization of variant translocations in chronic myelogenous leukemia.
Verma RS; Macera MJ; Benn P; Groffen J
Oncogene; 1989 Sep; 4(9):1145-8. PubMed ID: 2674857
[TBL] [Abstract][Full Text] [Related]
36. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ
Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864
[TBL] [Abstract][Full Text] [Related]
37. Interpretation of submicroscopic deletions of the BCR or ABL gene should not depend on extra signal-FISH: problems in interpretation of submicroscopic deletion of the BCR or ABL gene with extra signal-FISH.
Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Lee YK; Chun H; Kim HC; Lee DS
Genes Chromosomes Cancer; 2005 May; 43(1):37-44. PubMed ID: 15723338
[TBL] [Abstract][Full Text] [Related]
38. Co-detection of chimeric bcr/abl (target) and beta-actin (control) messenger RNA in individual CFU-GM colonies derived from CML patients using the polymerase chain reaction.
Wisniewski D; Strife A; Clarkson B
Leuk Res; 1991; 15(9):867-74. PubMed ID: 1921462
[TBL] [Abstract][Full Text] [Related]
39. Heterogeneity of genomic fusion of BCR and ABL in Philadelphia chromosome-positive acute lymphoblastic leukemia.
Rubin CM; Carrino JJ; Dickler MN; Leibowitz D; Smith SD; Westbrook CA
Proc Natl Acad Sci U S A; 1988 Apr; 85(8):2795-9. PubMed ID: 2833755
[TBL] [Abstract][Full Text] [Related]
40. Molecular consequences of the BCR-ABL translocation in chronic myelogenous leukemia.
Sawyers CL
Leuk Lymphoma; 1993; 11 Suppl 2():101-3. PubMed ID: 8124222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
